TOKYO (Reuters) – Japan’s Health Ministry committee on Wednesday recommended approval Pfizer Inc (NYSE:) COVID-19 vaccine for babies up to six months old.
Japan in January expanded the use of the vaccine to those as young as five years old. Last month, health authorities began dispensing with Pfizer and Moderna (NASDAQ 🙂 Inc Booster shots target the Omicron variant of the virus.
The committee also recommended approval of a version of the Pfizer vaccine that protects against the BA.4 and BA.5 sub variants of Omicron. Moderna said earlier on Wednesday it was seeking Japanese approval for its replacement injection.